| 684 |
abnormal |
embryo development
(GO:0009790)
|
|
1295: Defect of Embryogenesis
|
| 683 |
abnormal |
signaling
(GO:0023052)
|
Wnt signalosome
(GO:1990909)
|
1294: Inhibition, Wnt pathway
|
| 682 |
increased |
signaling
(GO:0023052)
|
forkhead box protein O (Caenorhabditis elegans)
(PR:O16850)
|
1293: Activation, FOXO
|
| 681 |
increased |
signaling
(GO:0023052)
|
JNK Mitogen-Activated Protein Kinases
(MESH:D048031)
|
1292: Activation, JNK
|
| 680 |
abnormal |
|
glutathione
(CHEBI:16856)
|
1290: Glutathione homeostasis
|
| 679 |
abnormal |
|
cholesterol
(CHEBI:16113)
|
1289: Perturbation of cholesterol
|
| 678 |
decreased |
glutathione biosynthetic process
(GO:0006750)
|
glutathione
(CHEBI:16856)
|
1287: Glutathione synthesis
|
| 677 |
decreased |
glutathione transferase activity
(GO:0004364)
|
glutathione S-transferase
(PR:000029945)
|
1286: Down Regulation, GSS and GSTs gene
|
| 676 |
decreased |
glutathione synthase activity
(GO:0004363)
|
glutathione synthetase
(PR:000008293)
|
1286: Down Regulation, GSS and GSTs gene
|
| 675 |
increased |
unsaturated fatty acid biosynthetic process
(GO:0006636)
|
unsaturated fatty acid
(CHEBI:27208)
|
1285: Up Regulation, Unsaturated fatty acid
|
| 674 |
increased |
gene expression
(GO:0010467)
|
sterol regulatory element-binding protein 2 proteolytic cleavage product
(PR:000021564)
|
1284: Up Regulation, SREBF2
|
| 673 |
increased |
signaling
(GO:0023052)
|
TGF-beta
(PR:000000046)
|
1283: Activation, TGF-beta pathway
|
| 672 |
increased |
signaling
(GO:0023052)
|
signal transducer and transcription activator STAT
(PR:000001933)
|
1282: Activation, JAK/STAT pathway
|
| 671 |
increased |
signaling
(GO:0023052)
|
Janus kinase
(PR:000025748)
|
1282: Activation, JAK/STAT pathway
|
| 670 |
increased |
DNA repair
(GO:0006281)
|
deoxyribonucleic acid
(CHEBI:16991)
|
1281: Increased, DNA Damage-Repair
|
| 669 |
increased |
signaling
(GO:0023052)
|
hypoxia-inducible factor 1 (Caenorhabditis elegans)
(PR:G5EGD2)
|
1280: Activation, HIF-1
|
| 668 |
increased |
signaling
(GO:0023052)
|
map kinase p38
(PR:000003106)
|
1279: Increase, Oxidative Stress / Activation, PMK-1 P38 MAPK
|
| 667 |
increased |
biosynthetic process
(GO:0009058)
|
reactive oxygen species
(CHEBI:26523)
|
None
|
| 666 |
increased |
signaling
(GO:0023052)
|
NADPH Oxidase
(MESH:D019255)
|
1174: Activation, NADPH Oxidase
|
| 665 |
abnormal |
plasma membrane organization
(GO:0007009)
|
|
1259: narcosis
|
| 664 |
decreased |
function
(MI:0613)
|
mitochondrion
(GO:0005739)
|
1260: Direct mitochondrial inhibition
|
| 663 |
abnormal |
cellular component organization
(GO:0016043)
|
|
1258: Decompartmentalization
|
| 662 |
occurrence |
Translocation, Genetic
(MESH:D014178)
|
|
1253: MLL chromosomal translocation
|
| 661 |
abnormal |
DNA topoisomerase II activity
(GO:0061505)
|
|
1252: Binding to (interferes with) topoisomerase II enzyme
|
| 660 |
abnormal |
|
Food Chain
(MESH:D020387)
|
1210: Alteration, Food-web structures
|